World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
50
Citations
8937
World Ranking
4455
National Ranking
102

Roger D. Kouyos publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Roger D. Kouyos sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 295 publications — 76th percentile

76% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Roger D. Kouyos D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Roger D. Kouyos sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 50 D-Index — 21st percentile

21% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Roger D. Kouyos is affiliated with the University of Zurich in Switzerland. Their research primarily spans the fields of Medicine and Immunology and Microbiology, with a focus on Infectious Diseases, Virology, Epidemiology, Emergency Medicine, and Immunology.

The main topics covered in their work include:

  • HIV Research and Treatment
  • HIV/AIDS Research and Interventions
  • HIV/AIDS drug development and treatment
  • HIV-related health complications and treatments
  • HIV, Drug Use, Sexual Risk
  • SARS-CoV-2 and COVID-19 Research
  • Pneumocystis jirovecii pneumonia detection and treatment

Roger D. Kouyos has contributed to a variety of frequent publication venues, including:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Clinical Infectious Diseases
  • The Journal of Infectious Diseases
  • Open Forum Infectious Diseases
  • BMC Infectious Diseases

Recent papers authored or co-authored by Roger D. Kouyos include:

  • Cohort Profile Update: The Swiss HIV Cohort Study (SHCS), 2021, International Journal of Epidemiology
  • HIV-1 drug resistance in people on dolutegravir-based antiretroviral therapy: a collaborative cohort analysis, 2023, The Lancet HIV
  • A highly virulent variant of HIV-1 circulating in the Netherlands, 2022, Science
  • Efficient microbial colony growth dynamics quantification with ColTapp, an automated image analysis application, 2020, Scientific Reports
  • A Treatment-as-Prevention Trial to Eliminate Hepatitis C Among Men Who Have Sex With Men Living With Human Immunodeficiency Virus (HIV) in the Swiss HIV Cohort Study, 2020, Clinical Infectious Diseases

The scientist collaborates frequently with several co-authors, including:

  • Huldrych F. Günthard
  • Enos Bernasconi
  • Matthias Cavassini
  • Dominique L. Braun
  • Alexandra Calmy

Best Publications

  • Population biological principles of drug-resistance evolution in infectious diseases

    Pia Abel zur Wiesch;Roger Kouyos;Jan Engelstädter;Roland R Regoes

  • Estimating the Basic Reproductive Number from Viral Sequence Data

    Tanja Stadler;Roger Kouyos;Viktor von Wyl;Sabine Yerly

  • Molecular Epidemiology Reveals Long-Term Changes in HIV Type 1 Subtype B Transmission in Switzerland

    Roger D. Kouyos;Viktor von Wyl;Sabine Yerly;Jürg Böni

  • Determinants of HIV-1 broadly neutralizing antibody induction

    Peter Rusert;Roger D Kouyos;Claus Kadelka;Hanna Ebner

  • Epistasis between deleterious mutations and the evolution of recombination.

    Roger D. Kouyos;Olin K. Silander;Sebastian Bonhoeffer

  • Contribution of a mutational bias in hepatitis C virus replication to the genetic barrier in the development of drug resistance

    Megan H. Powdrill;Egor P. Tchesnokov;Robert A. Kozak;Rodney S. Russell

  • Determinants of HIV-1 reservoir size and long-term dynamics during suppressive ART.

    Nadine Bachmann;Chantal von Siebenthal;Valentina Vongrad;Teja Turk

  • The state of affairs in the kingdom of the Red Queen

    Marcel Salathé;Roger D. Kouyos;Sebastian Bonhoeffer

  • Ambiguous Nucleotide Calls From Population-based Sequencing of HIV-1 are a Marker for Viral Diversity and the Age of Infection

    Roger D Kouyos;Viktor von Wyl;Sabine Yerly;Jürg Böni

  • Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case–control study using centralized ultrasensitive 454 pyrosequencing

    Alessandro Cozzi-Lepri;Marc Noguera-Julian;Francesca Di Giallonardo;Rob Schuurman

  • Phylogenetic Approach Reveals That Virus Genotype Largely Determines HIV Set-Point Viral Load

    Samuel Alizon;Viktor von Wyl;Tanja Stadler;Roger D. Kouyos

  • Prolonged persistence of measles virus RNA is characteristic of primary infection dynamics.

    Wen Hsuan W. Lin;Roger D. Kouyos;Robert J. Adams;Bryan T. Grenfell;Bryan T. Grenfell

  • Cohort Profile Update: The Swiss HIV Cohort Study (SHCS).

    Alexandra U Scherrer;Anna Traytel;Dominique L Braun;Alexandra Calmy

  • Exploring the complexity of the HIV-1 fitness landscape.

    Roger D. Kouyos;Gabriel E. Leventhal;Trevor Hinkley;Mojgan Haddad

  • Frequency and Spectrum of Unexpected Clinical Manifestations of Primary HIV-1 Infection

    Dominique L. Braun;Roger D. Kouyos;Belinda Balmer;Christina Grube

  • Inferring epidemic contact structure from phylogenetic trees.

    Gabriel E. Leventhal;Roger D. Kouyos;Tanja Stadler;Viktor von Wyl

  • Stochastic or deterministic: what is the effective population size of HIV-1?

    Roger D. Kouyos;Christian L. Althaus;Sebastian Bonhoeffer

  • HIV-1 drug resistance in people on dolutegravir-based antiretroviral therapy: a collaborative cohort analysis.

    Unknown

  • Hospital-community interactions foster coexistence between methicillin-resistant strains of Staphylococcus aureus.

    Roger Kouyos;Eili Klein;Eili Klein;Eili Klein;Bryan T. Grenfell

  • The path of least resistance: aggressive or moderate treatment?

    Roger D. Kouyos;Roger D. Kouyos;C. Jessica E. Metcalf;C. Jessica E. Metcalf;Ruthie Birger;Eili Y. Klein;Eili Y. Klein

  • Cycling empirical antibiotic therapy in hospitals: meta-analysis and models.

    Pia Abel zur Wiesch;Roger Kouyos;Sören Abel;Wolfgang Viechtbauer

  • Hepatitis C virus transmission among human immunodeficiency virus-infected men who have sex with men: Modeling the effect of behavioral and treatment interventions.

    Luisa Salazar‐Vizcaya;Roger D. Kouyos;Cindy Zahnd;Gilles Wandeler

Frequent Co-Authors

Huldrych F. Günthard
Huldrych F. Günthard University of Zurich
Enos Bernasconi
Enos Bernasconi Universita della Svizzera Italiana
Jürg Böni
Jürg Böni University of Zurich
Matthias Cavassini
Matthias Cavassini University of Lausanne
Sabine Yerly
Sabine Yerly University of Geneva
Manuel Battegay
Manuel Battegay University Hospital of Basel
Thomas Klimkait
Thomas Klimkait University of Basel
Andri Rauch
Andri Rauch University of Bern
Alexandra Calmy
Alexandra Calmy University of Geneva

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying microbiology in the USA opens doors to diverse career opportunities, many of which can be pursued through flexible online programs. For those with unique circumstances, there are online colleges that accept felons, making education more accessible to a broader group of learners.

One emerging pathway is toward healthcare roles such as a functional medicine nurse practitioner. This career combines microbiological knowledge with patient care in holistic treatment approaches, showcasing the interdisciplinary possibilities of a microbiology background.

For those interested in the administrative or billing side of healthcare, becoming a CPC (Certified Professional Coder) offers a specialized avenue to apply scientific knowledge in managing health information efficiently.

Similarly, the role of a health information manager salary reflects growing demand for professionals skilled in overseeing medical data and records—a critical function that benefits from a solid foundation in microbiological sciences.

Best Scientists Citing Roger D. Kouyos

Trending Scientists

Recently Published Articles